VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 492 filers reported holding VANECK VECTORS ETF TR in Q3 2019. The put-call ratio across all filers is 0.82 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $9,256,000 | +22.1% | 362,111 | +7.1% | 0.06% | +22.2% |
| Q1 2019 | $7,579,000 | +21.8% | 338,038 | +14.6% | 0.04% | +2.3% |
| Q4 2018 | $6,222,000 | +13.9% | 295,009 | 0.0% | 0.04% | +18.9% |
| Q3 2018 | $5,464,000 | -21.6% | 295,009 | -5.5% | 0.04% | -21.3% |
| Q2 2018 | $6,968,000 | +4.2% | 312,305 | +2.7% | 0.05% | +6.8% |
| Q1 2018 | $6,686,000 | -22.7% | 304,192 | -18.3% | 0.04% | -26.7% |
| Q4 2017 | $8,654,000 | +20.0% | 372,374 | +18.5% | 0.06% | -9.1% |
| Q3 2017 | $7,213,000 | +20.9% | 314,152 | +16.3% | 0.07% | +11.9% |
| Q2 2017 | $5,965,000 | -3.2% | 270,143 | 0.0% | 0.06% | -7.8% |
| Q1 2017 | $6,162,000 | -7.9% | 270,143 | -15.6% | 0.06% | -13.5% |
| Q4 2016 | $6,693,000 | -14.1% | 319,952 | +8.5% | 0.07% | -32.1% |
| Q3 2016 | $7,793,000 | +15.9% | 294,867 | +21.5% | 0.11% | +25.3% |
| Q2 2016 | $6,725,000 | – | 242,788 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
| Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
| New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
| Brown University | 541,096 | $19,490,000 | 14.10% |
| Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
| New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
| Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
| Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
| tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |